NeuroBytes: Diagnosing Neuromyelitis Optica Spectrum Disorders (Second Edition)
Course Description
In 2015, the International Panel for NMO Diagnosis introduced new consensus diagnostic criteria for neuromyelitis optica spectrum disorders (NMOSD). These new diagnostic criteria incorporate aquaporin-4 antibody status and allows for potentially earlier diagnosis of NMOSD. Our aim in this video is to review these latest diagnostic criteria.
Learning Objectives
As a result of this program the learner will be able to:
- Discuss the diagnostic criteria for Neuromyelitis Optica Spectrum Disorder
Date of Release
June 26, 2020
Rereleased August 4, 2023
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete
Terms of Use.
Faculty & Disclosures
TYLER ELLIS SMITH, MD
Neurology Chief Resident
Ochsner Clinic Foundation
New Orleans, LA
*Dr. Smith has nothing to disclose.
Editor
Neurology Chief Resident
Ochsner Clinic Foundation
New Orleans, LA
*Dr. Smith has nothing to disclose.
Editor
JOSE POSAS, MD
Senior Physician
Neurology Residency Program Director
Ochsner Clinic Foundation
*Dr. Posas has nothing to disclose.
Reviewer
ZACHARY N. LONDON, MD, FAAN
Professor
University of Michigan
Ann Arbor, Michigan
*Dr. London has nothing to disclose.
NeuroBytes Staff
Amanda Chamberlain, Associate Director, eLearning
Minneapolis, MN
*Ms. Chamberlain has nothing to disclose.
Robert Rook, eLearning Program Manager
Minneapolis, MN
*Mr. Rook has nothing to disclose.
Beth Rogers-Baggett, eLearning & LMS Coordinator
Minneapolis, MN
*Ms. Rogers-Baggett has nothing to disclose.
*Relationship Disclosure